 |
ledipasvir/sofosbuvir |
|---|---|
| Trade Name | Harvoni |
| Orphan Indication | Chronic hepatitis C virus (HCV) infection in pediatric patients |
| USA Market Approval | USA |
| USA Designation Date | 2016-10-12 00:00:00 |
| Sponsor | Gilead Sciences, Inc.;333 Lakeside Drive;Foster City, California, 94404 |
